Alkermes (ALKS) Operating Margin (2010 - 2026)
Alkermes (ALKS) reported Operating Margin of 122.23% for Q1 2026, down 12673.0% year-over-year from N/an in Q1 2025, and down 908.93% quarter-over-quarter from 15.11% in Q4 2025.
Alkermes (ALKS) Operating Margin (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Operating Margin data on file, last reported at 122.23% in Q1 2026.
- Operating Margin for Q1 2026 came in at 122.23%, down 12673.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 15.87% (down 996.0% YoY), and the FY2025 annual result was 17.21%, down 980.0% from the prior year.
- Operating Margin retreated to 122.23% in Q1 2026 per ALKS's latest filing, from 15.11% in the prior quarter.
- Over five years, Operating Margin peaked at 45.56% in Q2 2023 and troughed at 1895.03% in Q3 2022.
- A 5-year average of 171.2% and a median of 15.11% in 2025 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2022 and 2023: Operating Margin slumped 188835 bps in 2022, then jumped 191845 bps in 2023.
- A 5-year view of Operating Margin shows it stood at 37.94% in 2022, then slumped by 314 bps to 81.28% in 2023, then soared by 147 bps to 37.84% in 2024, then slumped by 60 bps to 15.11% in 2025, then sank by 909 bps to 122.23% in 2026.
- Business Quant data shows ALKS's Operating Margin at 122.23% in Q1 2026, 15.11% in Q4 2025, and 22.6% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -122.23% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -12.88% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 46.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.23% |
| Dec 31, 2025 | 15.11% |
| Sep 30, 2025 | 22.60% |
| Jun 30, 2025 | 23.80% |
| Mar 31, 2025 | 4.50% |
| Dec 31, 2024 | 37.84% |
| Sep 30, 2024 | 27.70% |
| Jun 30, 2024 | 27.53% |
| Mar 31, 2024 | 12.36% |
| Dec 31, 2023 | -81.28% |
| Sep 30, 2023 | 23.41% |
| Jun 30, 2023 | 45.56% |
| Mar 31, 2023 | -3.82% |
| Dec 31, 2022 | 37.94% |
| Sep 30, 2022 | -1,895.03% |
| Jun 30, 2022 | -1,076.78% |
| Mar 31, 2022 | -9.54% |
| Dec 31, 2021 | 39.89% |
| Sep 30, 2021 | -6.68% |
| Jun 30, 2021 | 1.46% |